IB Net Payout Yields Model

Teledoc: More Downside Ahead

Teledoc (TDOC) is at the center of digital health. My previous research was for investors to 'pump the brakes' when the stock originally hit $60. The stock went on to surge to absurd levels reaching a high of $89. It's very crucial for investors to understand that Teledoc trading this far from the highs doesn't necessarily make the stock a bargain.

The stock now trades at a market value of about $4 billion with '19 sales estimates of $550 million. Teledoc probably hits a buy zone down at $45 or when the price hits $3.3 billion or roughly 6x sales estimates.

Disclosure: No position. Please review the disclaimer page for more details. 


Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

Celsius: Unaltered Growth Story

Hims & Hers Health: Still Firing On Strong Cylinders